Found 0 matching trials
Acute Effects of Intravenous 5-MeO-DMT in Healthy Participants
PHASE1Participation in this study lasts approximately two weeks and includes thre...
Location
University Hospital Basel
Effects of Dimethyltryptamine in Healthy Subjects
PHASE1N,N-dimethyltryptamine (DMT) is a naturally-occurring psychedelic substance...
Location
University Hospital Basel
Pharmacokinetics of GH001 in Healthy Volunteers
PHASE1The primary objective of this study is to investigate the serum pharmacokin...
Location
GH Research Clinical Trial Site
Phase 2 Clinical Trial of GH001 in Bipolar II Disorder
PHASE2This study is a multicenter, open-label, single-arm Phase 2 clinical trial....
Location
Investigational Site
Inhaled DMT for Major Depressive Disorder
PHASE2This Phase 2b, randomized, double-blind, active-controlled clinical trial w...
Location
Hospital de Saúde Mental Professor Frota Pinto
Antidepressant Response of DMT Masked With Propofol
NAThe aim of this study is to elucidate if the anti-depressive effect of N,N-...
Location
University Hospital Basel
Fixed Order, Open-Label, Dose-Escalation Study of DMT in Humans
PHASE1The goal of this fixed order, open-label, dose-escalation study is to inves...
Status
Active Not Recruiting
Location
Biological Studies Unit at the VA Connecticut Healthcare System, Yale School of Medicine
Psilocybin Therapy for Chronic Low Back Pain
PHASE1This study evaluates whether psilocybin therapy helps patients cope with ch...
Status
Active Not Recruiting
Location
University of California San Francisco
Dose-finding Study for the Combination of DMT and Harmine in Healthy Subjects
PHASE1The goal of this clinical trial is to compare corresponding inter- and intr...
Location
University Hospital of Psychiatry Zurich
Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease
PHASE2The purpose of this study is to determine the safety, tolerability, and fea...
Location
University of California, San Francisco